FIELD: chemistry.
SUBSTANCE: described are piperazine indoles of general formula , in which R1 represents 2-indanyl, R2 represents 1-methylpropyl, R3 and R4 together with nitrogen atoms to which they are bonded represent a morpholino group, and pharmaceutically acceptable salts thereof. Also described is a pharmaceutical composition based on formula (I) compound.
EFFECT: compounds have antagonistic effect on oxytocin receptor.
6 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | 2002 |
|
RU2303032C2 |
SUBSTITUTED DIKETOPIPERAZINS AND THEIR APPLICATION AS OXYTOCENE ANTAGONISTS | 2004 |
|
RU2343152C2 |
PIPERIDINE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2016 |
|
RU2730508C2 |
BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
METHOD FOR PREPARING DIHYDROINDENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USING THEM AS PROTEIN KINASE INHIBITOR | 2009 |
|
RU2528408C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR | 2016 |
|
RU2718917C2 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
COMPOUNDS SUITABLE FOR THERAPY AGAINST HIV | 2019 |
|
RU2806030C2 |
PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | 2008 |
|
RU2490265C2 |
Authors
Dates
2010-02-20—Published
2005-06-21—Filed